Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000412897

Medchemexpress LLC Protoporphyrin IX | 553-12-8 | MFCD00151109 | 98.0% | 100 MG
SDP

Catalog No. 5000412897
Encompass_Preferred

Protoporphyrin IX is an endogenous metabolite and a final intermediate in the heme biosynthetic pathway. It functions as a radiation sensitizer, enhancing ROS generation even in hypoxic conditions and inducing DNA damage. It also acts as a photosensitizer that undergoes photobleaching from light irradiation. It accumulates in tumor cells after administration of 5-aminolevulinic acid (5-ALA).

  • Endogenous metabolite and final intermediate in heme biosynthetic pathway
  • Functions as a radiation sensitizer
  • Enhances ROS generation even in hypoxic conditions
  • Induces DNA damage
  • Acts as a photosensitizer that undergoes photobleaching from light irradiation
  • Accumulates in tumor cells after administration of 5-aminolevulinic acid (5-ALA)
  • Shows promise as a sonodynamic and photodynamic agent for various cancers, such as bladder cancer and nodular basal cell carcinoma

Catalog No. 50-004-12897 Supplier Medchemexpress LLC Supplier No. HYB1247R100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Protoporphyrin IX is an endogenous metabolite and a final intermediate in the heme biosynthetic pathway. It functions as a radiation sensitizer, enhancing ROS generation even in hypoxic conditions and inducing DNA damage. It also acts as a photosensitizer that undergoes photobleaching from light irradiation. It accumulates in tumor cells after administration of 5-aminolevulinic acid (5-ALA).

  • Endogenous metabolite and final intermediate in heme biosynthetic pathway
  • Functions as a radiation sensitizer
  • Enhances ROS generation even in hypoxic conditions
  • Induces DNA damage
  • Acts as a photosensitizer that undergoes photobleaching from light irradiation
  • Accumulates in tumor cells after administration of 5-aminolevulinic acid (5-ALA)
  • Shows promise as a sonodynamic and photodynamic agent for various cancers, such as bladder cancer and nodular basal cell carcinoma

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.